Company profile: Virdante Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of biopharmaceutical therapies, developing and commercializing drugs for autoimmune and inflammatory diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Virdante Pharmaceuticals
Receptos
HQ: United States
Website
- Description: Provider of drug discovery, development and commercialization of therapeutics for immune disorders, leveraging pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for best- and first-in-class drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Receptos company profile →
SetPoint Medical
HQ: United States
Website
- Description: Provider of neuroimmune modulation solutions for chronic autoimmune conditions, including a platform that activates immunomodulatory pathways via targeted electrical stimulation to regulate inflammation, and a small vagus nerve stimulation device with integrated circuit, telemetry and rechargeable battery controlled via iPad. Also conducts clinical research, including RESET-RA, a randomized, double-blind rheumatoid arthritis study.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SetPoint Medical company profile →
Epiva
HQ: United States
Website
- Description: Provider of immuno-microbiome therapeutics, developing immunobiotic therapeutics through a platform from Flagship VentureLabs, the innovation foundry of Flagship Ventures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epiva company profile →
CytoDyn
HQ: United States
Website
- Description: Provider of biotechnology therapies developing Leronlimab, a CCR5-targeting humanized monoclonal antibody for HIV to prevent viral entry into T-cells; exploring uses in NASH to address liver health, fibrosis and cirrhosis; oncology to inhibit tumor growth and metastasis; COVID-19 to modulate immune response and potentially reduce inflammation; and pre-clinical glioblastoma studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CytoDyn company profile →
Phenex Pharmaceuticals
HQ: Germany
Website
- Description: Provider of drug discovery and development focused on novel pharmaceuticals, leveraging small-molecule expertise. Privately held, founded in 2002, with Biology and Chemistry laboratories and offices in the Biotech Cluster Rhine-Neckar, primarily in Heidelberg and partly in Ludwigshafen.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phenex Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Virdante Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Virdante Pharmaceuticals
2.2 - Growth funds investing in similar companies to Virdante Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Virdante Pharmaceuticals
4.2 - Public trading comparable groups for Virdante Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →